Levothyroxine vs T4/T3 Combination Therapy
A real problem, and an unproven solution
The 30-second view
- Recommended as monotherapy of choice
- Not routinely recommended
- The comparator
- Generally not demonstrated
- Body converts T4 to T3 as needed
- Some argue conversion is inadequate in a subset
- Stable; long half-life
- T3 has a short half-life — peaks and troughs
- Over-replacement (AF, bone loss)
- Same, plus harder to monitor
| Dimension | Levothyroxine (T4 alone) | T4/T3 Combination |
|---|---|---|
| Guideline status | Recommended as monotherapy of choice | Not routinely recommended |
| Trial evidence of superiority | The comparator | Generally not demonstrated |
| Physiological rationale | Body converts T4 to T3 as needed | Some argue conversion is inadequate in a subset |
| Dosing stability | Stable; long half-life | T3 has a short half-life — peaks and troughs |
| Risk | Over-replacement (AF, bone loss) | Same, plus harder to monitor |
Overview
Most people with hypothyroidism do well on levothyroxine. A genuine subset do not — they remain symptomatic despite a normal TSH. T4/T3 combination therapy is the most popular proposed solution to that problem, and this comparison exists to be honest about both halves of the situation.
Quick summary
When each is appropriate
Standard treatment for hypothyroidism — effective for the large majority.
Considered only by a specialist, in persistently symptomatic patients with a normal TSH, after other causes have been excluded — and with clear-eyed expectations.
Evidence comparison
- Supported
- No added benefit demonstrated
- The comparator
- Not demonstrated in trials
- Most do well
- Some patients report preferring it
- N/A
- None reliably identified
- Yes
- Not routine
- Straightforward (TSH)
- More complex; TSH less reliable as a guide
| Dimension | Levothyroxine (T4 alone) | T4/T3 Combination |
|---|---|---|
| Symptom resolution (most patients) | Supported | No added benefit demonstrated |
| Superiority in persistent symptoms | The comparator | Not demonstrated in trials |
| Patient preference | Most do well | Some patients report preferring it |
| Identified benefiting subgroup | N/A | None reliably identified |
| Guideline recommendation | Yes | Not routine |
| Monitoring complexity | Straightforward (TSH) | More complex; TSH less reliable as a guide |
Safety comparison
- Over-replacement causes atrial fibrillation and bone loss
- Same risks, plus T3's short half-life produces peaks that are harder to monitor
| Dimension | Levothyroxine (T4 alone) | T4/T3 Combination |
|---|---|---|
| Common issues | Over-replacement causes atrial fibrillation and bone loss | Same risks, plus T3's short half-life produces peaks that are harder to monitor |
Strengths & limitations
Levothyroxine (T4 alone)
T4/T3 Combination
Frequently asked questions
I still feel terrible on levothyroxine. Should I demand T3?
Your symptoms are real and you deserve to be taken seriously — that part is not in question. But the honest evidence is that T3 combination therapy has not been shown superior in trials, and no group that reliably benefits has been identified. Before pursuing it, it's worth excluding the other conditions that produce identical symptoms: anaemia, low B12, sleep apnoea, and depression all overlap heavily with hypothyroidism, and all are treatable.
What about natural desiccated thyroid?
It is not a better option. Desiccated thyroid extract delivers a T3:T4 ratio that doesn't match human physiology, and its potency varies between batches. It is not recommended in guidelines. Here, 'natural' means less consistent — not better.
Where to go next
Related Foundations
Related Signal Records
Related biomarkers
Related conditions
Related body systems
References & sources
- ATA Guidelines for the Treatment of Hypothyroidism
- Randomised trials of T4/T3 combination therapy
Educational information — not medical advice
Is this comparison clear, balanced, and useful? Your feedback shapes what we review next.
Give feedback